If you have colon or rectal cancer that has spread to other areas of the body (metastasized), your healthcare provider may prescribe Camptosar® (irinotecan) to help slow down the progression of the cancer. This medicine is specifically approved for use in people age 18 and older. It can be used alone or in combination with certain other chemotherapy drugs.
Camptosar comes as a solution that is given slowly into a vein using an intravenous (IV) infusion. A healthcare provider will administer the medicine every one to three weeks.
Before starting chemotherapy treatment with Camptosar, make sure to review the drug's safety information with your healthcare provider. For example, you may not be able to use this medicine if you have certain allergies or if you are taking certain medications. Possible side effects of Camptosar include diarrhea, nausea, and vomiting.
(Click Camptosar for more information on this chemotherapy drug, including how it works, dosing instructions, and what to expect during treatment.)
Written by/reviewed by: Arthur Schoenstadt, MD
Last reviewed by: ArthurSchoenstadt, MD
List of references (click here):
Camptosar [package insert]. New York, NY: Pharmacia & Upjohn Company;2011 June.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed January 17, 2012.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed January 18, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click